Retina Reports

The “2025 Exudative Retinal Disease Pharmaceuticals Market Report” delivers a comprehensive analysis of anti-VEGFs and other therapies for exudative retinal diseases. It highlights key market trends, growth drivers, and future opportunities, with five-year forecasts in units and dollars for branded ocular anti-VEGFs, cancer drugs used off-label, biosimilars, and sustained-drug-delivery devices. The report also breaks down market share by product category and profiles 29 leading competitors, detailing their products, strategies, and market positioning. 

The “2025 Nonexudative Retinal Disease Pharmaceuticals Market Report” delivers a comprehensive analysis of current and emerging therapies for geographic atrophy, dry AMD, and other nonexudative retinal diseases. It evaluates complement inhibitors, gene therapies, sustained-release technologies, antioxidants, and more—examining key market trends, patient economics, reimbursement dynamics, and five-year growth forecasts.  

The report also includes detailed unit and dollar demand projections, product category market shares, and profiles of 19 leading competitors with insights into their strategies and outlooks. 

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Market Report” is the definitive resource for understanding the global ophthalmic diagnostic landscape. This edition delivers in-depth analysis of the current markets for diagnostic equipment in cataract and refractive surgery, refracting and screening instruments, and emerging technologies. It also provides five-year global forecasts, along with regional and economic analyses across the US, Western Europe, Japan, other wealthy nations, China, India, Latin America, and developing markets worldwide. 

The report considers more than 800 devices from 115 manufacturers, covering technologies that span corneal topographers, anterior eye scanners, biometers, tonometers, fundus cameras, perimeters, refractors, slit lamps, and advanced microscopy systems. 

Each section includes market sizing, pricing trends, competitor market share, installed equipment base, and company profiles, giving manufacturers, investors, and eye care providers the actionable intelligence needed to navigate competitive dynamics, plan strategic growth, and anticipate technological innovation.  

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

The 2025 China Ophthalmic Market Report delivers a comprehensive analysis of China’s rapidly evolving ophthalmic sector, analyzing the demographic trends and economic conditions that will shape the future of the market. The report offers deep insights into disease prevalence, highlights commercialized products and promising pipeline assets, and forecasts unit demand, sales revenue, and market performance through 2030. Competitive dynamics are thoroughly analyzed across product categories, and the report provides detailed profiles of 32 major competitors, their product portfolios, strategic positions, and future outlooks.  

Market Scope’s “2025 European Five Ophthalmic Market Report” dives into Western Europe’s top five ophthalmic markets—France, Germany, Italy, Spain, and the United Kingdom—exploring 11 ophthalmic submarkets with insights on crucial trends and factors for success. The report reviews current market landscapes, projects market performance through 2030, forecasts disease prevalence, analyzes treatment volumes, and reviews emerging technologies and profiles key competitors. 

The “2024 Ophthalmic Landscape Report” offers a high-level analysis of the ophthalmic market by region and subspecialty and forecasts market performance of nine product categories through 2029. The report analyzes important trends, reviews key factors for future success, comprehensively details the competitive landscape in ophthalmology, and compares the ophthalmic sector across health care and other related markets. 

The “2025 Retinal Device Market Report” provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2024 market and forecasts market growth and evolution through 2029. Additionally, 19 retina device companies are profiled, with discussion of their products, strategic market position, background, and outlook. 

Market Scope’s "2024 Retinal Disease Model" offers extensive country-level prevalence data and five-year forecasts for retinal diseases and conditions by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

The “2023 United States Retina Atlas” provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Retina Atlas offers strategic insights into the top potential markets in the US by providing:

• Demographic information of selected metropolitan populations
• Profiles of selected metropolitan areas and applicable retinal treatment opportunity
• Current estimates for retinal surgery volume by metropolitan area
• Current estimates for retina surgeons by metropolitan area
• Comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies